×
About 6,170 results

ALLMedicine™ Hepatic Encephalopathy Center

Research & Reviews  1,939 results

Heart rate variability is associated with encephalopathy and outcomes in pediatric acut...
https://doi.org/10.1038/s41390-022-02225-2
Pediatric Research; Pendergrast TR, Chapin CA et. al.

Aug 5th, 2022 - More than half of children with pediatric acute liver failure (PALF) experience hepatic encephalopathy (HE), which is related to poor outcomes; however, HE is difficult to diagnose in children. The objective of this study was to evaluate if heart ...

Sodium-glucose cotransporter-2 inhibition exacerbates hepatic encephalopathy in biliary...
https://doi.org/10.1124/jpet.122.001289
The Journal of Pharmacology and Experimental Therapeutics; Hsu SJ, Huang HC et. al.

Aug 5th, 2022 - In liver cirrhosis, hepatic inflammation and abundant portal-systemic collaterals are indicated for the development of hepatic encephalopathy. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are a type of anti-diabetic agent, which exert pleiot...

A meta-analysis of the association between Helicobacter pylori infection and risk of he...
https://doi.org/10.1093/pubmed/fdac078
Journal of Public Health (Oxford, England); Li J, Yu H et. al.

Aug 5th, 2022 - Although the association between Helicobacter pylori (H. pylori) infection and hepatic encephalopathy (HE) has been confirmed through some research, the results of these relevant studies still remain controversial. We conducted an updated meta-ana...

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases
https://clinicaltrials.gov/ct2/show/NCT04698148

Aug 4th, 2022 - The primary aim of this multicentric study is to populate the first national microbioma biobank with biological samples (fecal, salivary, urinary and blood samples) subjects suffering from selected disease (CDI, MDRO, IBD, IBS and Hepatic Encephal...

Serum Levels of Some Trace Elements in Hepatocellular Carcinoma Patients
https://clinicaltrials.gov/ct2/show/NCT05488587

Aug 4th, 2022 - Hepatocellular carcinoma (HCC) is the sixth most frequent malignancy worldwide, with an estimated 906,000 new cases and 830,000 deaths in 2020. It is also the third leading cause for cancer deaths , with 15% 5-year survival rate. Diagnosis of HCC ...

see more →

Guidelines  6 results

EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.
https://doi.org/10.1016/j.jhep.2022.06.001
Journal of Hepatology; ,

Jun 21st, 2022 - EASL Clinical Practice Guidelines on the management of hepatic encephalopathy.|2022| , ,|

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160350
Clinical and Molecular Hepatology;

Jan 11th, 2020 - KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.|2020| ,|

Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767982
World Journal of Gastroenterology; Xu XY, Ding HG et. al.

Oct 3rd, 2019 - The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and...

Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediat...
https://doi.org/10.1016/j.bbmt.2017.08.035
Biology of Blood and Marrow Transplantation : Journal of ... Ovchinsky N, Frazier W et. al.

Sep 6th, 2017 - Some patients with veno-occlusive disease (VOD) have multiorgan dysfunction, and multiple teams are involved in their daily care in the pediatric intensive care unit. Cardiorespiratory dysfunction is critical in these patients, requiring immediate...

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885589
European Journal of Gastroenterology & Hepatology; Shawcross DL, Dunk AA et. al.

Nov 26th, 2015 - Hepatic encephalopathy is defined as brain dysfunction caused by liver insufficiency and/or portosystemic shunting. Symptoms include nonspecific cognitive impairment, personality changes and changes in consciousness. Overt (symptomatic) hepatic en...

see more →

Drugs  29 results see all →

Clinicaltrials.gov  322 results

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases
https://clinicaltrials.gov/ct2/show/NCT04698148

Aug 4th, 2022 - The primary aim of this multicentric study is to populate the first national microbioma biobank with biological samples (fecal, salivary, urinary and blood samples) subjects suffering from selected disease (CDI, MDRO, IBD, IBS and Hepatic Encephal...

Serum Levels of Some Trace Elements in Hepatocellular Carcinoma Patients
https://clinicaltrials.gov/ct2/show/NCT05488587

Aug 4th, 2022 - Hepatocellular carcinoma (HCC) is the sixth most frequent malignancy worldwide, with an estimated 906,000 new cases and 830,000 deaths in 2020. It is also the third leading cause for cancer deaths , with 15% 5-year survival rate. Diagnosis of HCC ...

VE303 for Treatment of Hepatic Encephalopathy (HE)
https://clinicaltrials.gov/ct2/show/NCT04899115

Aug 2nd, 2022 - This research is studying the use of a new drug to learn about its safety and efficacy as a treatment for hepatic encephalopathy. Eligible participants will be enrolled and given oral antibiotics followed by 14 days of the study drug (placebo vs.V...

Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis-Child C
https://clinicaltrials.gov/ct2/show/NCT03633279

Jul 29th, 2022 - Globally, the mortality after any infection in cirrhosis patients is very high. The cumulative mortality in patients with infections was 43.5% (11,987 patients) where as the mortality rate without infection was 13.6% (2317 patients). Over the year...

Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis
https://clinicaltrials.gov/ct2/show/NCT05006430

Jul 27th, 2022 - Background: Alcoholic hepatitis (AH) is a major public health problem in the United States, caused by chronic alcohol consumption of more than 40-60 g/day. Approximately 5 million Americans are diagnosed with AH, contributing to 5% of US annual mo...

see more →

News  168 results

Past Decompensation in Alcoholic Hepatitis Not 'Absolute Contraindication' to Early Transplant
https://www.medscape.com/viewarticle/978309

Jul 29th, 2022 - Past decompensation in alcohol-associated hepatitis may be linked with worse survival following liver transplantation, but it's not all bad news, according to a retrospective study. Traditionally, patients with alcoholic liver disease were asked t...

Prior decompensation in alcohol-associated hepatitis not an ‘absolute contraindication’ for early liver transplant
https://www.mdedge.com/internalmedicine/article/256455/hepatology/prior-decompensation-alcohol-associated-hepatitis-not
Jim Kling

Jul 25th, 2022 - Past decompensation in alcohol-associated hepatitis may be linked with worse survival following liver transplantation, but it’s not all bad news, according to a retrospective study. Traditionally, patients with alcoholic liver disease were asked t.

Severe COVID-19 in Chronic Liver Disease Linked With Cholestasis and Secondary Sclerosing Cholangitis
https://www.medscape.com/viewarticle/976382

Jun 30th, 2022 - NEW YORK (Reuters Health) - Severe COVID-19 increases the risk for cholestasis and secondary sclerosing cholangitis (SSC) in patients with chronic liver disease (CLD), researchers say. Among 65 patients with preexisting CLD who were hospitalized f...

Are Pain Meds the Only Option for Chronic Pain in Cirrhosis?
https://www.medscape.com/viewarticle/976207

Jun 27th, 2022 - Pain is common in patients with cirrhosis, and its management presents significant challenges to health care providers, such as worries about GI bleeding, renal injury, falls, and hepatic encephalopathy. To address those issues, researchers at the...

Are pain meds the only option for chronic pain in cirrhosis?
https://www.mdedge.com/internalmedicine/article/255747/hepatology/are-pain-meds-only-option-chronic-pain-cirrhosis
Jim Kling

Jun 24th, 2022 - Pain is common in patients with cirrhosis, and its management presents significant challenges to health care providers, such as worries about GI bleeding, renal injury, falls, and hepatic encephalopathy. To address those issues, researchers at the.

see more →

Patient Education  4 results see all →